Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$86,217,875
+$13,806,442 QoQ
Shares Held
238,092
+15.7% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#164
of 3,140 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $1,229,733,122 across 9 Drug Manufacturers - General names. AMGN ranks #5 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
244,861 | $293,693,653 | |
| 2 | JNJ |
Johnson & Johnson
|
1,050,526 | $266,802,088 | |
| 3 | ABBV |
AbbVie Inc.
|
907,363 | $228,328,825 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,124,149 | $144,453,146 | |
| 5 | AMGN |
Amgen Inc
This page
|
238,092 | $86,217,875 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,167,476 | $67,269,967 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
528,600 | $66,783,324 | |
| 8 | PFE |
Pfizer Inc
|
2,154,713 | $51,885,489 |
All Filings in AMGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $86,217,875 | 238,092 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $72,411,433 | 205,802 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $59,391,708 | 181,454 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $42,867,873 | 151,906 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $51,211,581 | 183,416 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $112,045,530 | 359,639 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $93,592,696 | 359,088 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $99,224,569 | 307,950 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $91,276,955 | 292,133 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $43,260,140 | 152,153 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $42,050,920 | 146,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $21,500,800 | 80,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $72,808,572 | 327,937 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $18,829,182 | 77,887 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $19,894,980 | 75,750 | Shares | Sole | 2023-02-14 | |
| 2022-03-31 | $39,945,520 | 165,187 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $20,270,696 | 90,104 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $20,087,131 | 94,461 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $23,011,950 | 94,408 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $20,989,860 | 84,361 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $115,079,558 | 500,520 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||